Problems of the laboratory control of oral anticoagulant treatment
Hummel, L.
Folia Haematologica 115(4): 529-531
1988
ISSN/ISBN: 0323-4347 PMID: 2465967 Document Number: 305677
The paper deals with the estimation (using the Monte Carlo method) of a confidence interval for an individual patient's International Normalized Ratio (INR) of 3.3. The results show that this confidence interval ranges from an INR of 2.5 to 4.2 and is of about the same size as the therapeutic range.
Document emailed within 1 workday
Related Documents
Kopeć, M.; Lopaciuk, S. 1987: Problems of laboratory control of treatment with oral anticoagulants Polski Tygodnik Lekarski 42(30): 929-932Thomson, J.M.; Chart, I.S. 1970: The system for laboratory control of oral anticoagulant therapy using the British comparative thromboplastin Journal of Medical Laboratory Technology 27(2): 207-212
Tripodi, A.; Arbini, A.A.; Chantarangkul, V.; Bettega, D.; Mannucci, P.M. 1993: Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulant treatment by the international normalized ratio? Thrombosis and Haemostasis 70(6): 921-924
Tripodi, A.; Chantarangkul, V.; Clerici, M.; Mannucci, P.M. 2002: Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA Thrombosis and Haemostasis 88(4): 583-586
Brink, S.; Cloete, H.; Roberts, R.; Holm, W. 1976: Laboratory standardization and quality control in anticoagulant therapy South African Medical Journal 50(7): 205-208
van den Besselaar, A.M. 1990: Recommended method for reporting therapeutic control of oral anticoagulant therapy. Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis Thrombosis and Haemostasis 63(2): 316-317
Heene, D.L. 1974: Control of oral anticoagulant therapy using the Hepato-Quick-test Die Medizinische Welt 25(39): 1529-1531
Tripodi, A.; Cattaneo, M.; Molteni, A.; Cesana, B.M.; Mannucci, P.M. 1998: Changes of prothrombin fragment 1+2 (F 1+2) as a function of increasing intensity of oral anticoagulation--considerations on the suitability of F 1+2 to monitor oral anticoagulant treatment Thrombosis and Haemostasis 79(3): 571-573
Miale, J.B. 1979: Prothrombin time standardization report of the expert panel on oral anticoagulant control: a minority opinion Thrombosis and Haemostasis 42(4): 1132-1134
Wintzen, A.R.; Klasen, L.; Bussemaker, W.; Broekmans, A.W.; Loeliger, E.A. 1988: A retrospective study of the cause, treatment and course of cerebral hemorrhages during oral anticoagulant treatment Nederlands Tijdschrift Voor Geneeskunde 132(47): 2151-2154
Strengers, P.F.W.; Drenth, J.C. 2002: PPSB as first choice treatment in the reversal of oral anticoagulant therapy Acta Anaesthesiologica Belgica 53(3): 183-186
Triau, R.; Ayme, G.; Donikian, R.; Mynard, M.C.; Valette, L. 1970: Preparations and laboratory control of an oral anti-coli vaccine Progress in Immunobiological Standardization 4: 380-385
Engelken, H.J.; Martin, M. 1974: Discontinuation of oral anticoagulant therapy following fibrinolytic treatment in arterial occlusive disease Die Medizinische Welt 25(25): 1122-1124
Kyrle, P.A.; Brockmeier, J.; Weltermann, A.; Eichinger, S.; Speiser, W.; Lechner, K.; Eichler, H.G. 1997: Inhibition rather than enhancement of hemostatic system activation during initiation of oral anticoagulant treatment Thrombosis and Haemostasis 77(4): 685-689
Ruparelia, N.; Panoulas, V.F.; Frame, A.; Sutaria, N.; Ariff, B.; Gopalan, D.; Chukwuemeka, A.; Mikhail, G.W.; Malik, I.S. 2016: Successful Treatment of very Early Thrombosis of SAPIEN 3 Valve with Direct Oral Anticoagulant Therapy Journal of Heart Valve Disease 25(2): 211-213
Setiabudi, E.; Alwi, I.; Setiati, S. 2008: Oral anticoagulant treatment in management of elderly patients with atrial fibrillation [corrected]: is it beneficial or detrimental? Acta Medica Indonesiana 40(1): 40-47
Samama, M.; Horellou, M.H.; Soria, J.; Conard, J.; Nicolas, G. 1984: Successful progressive anticoagulation in a severe protein C deficiency and previous skin necrosis at the initiation of oral anticoagulant treatment Thrombosis and Haemostasis 51(1): 132-133
Palareti, G. 1996: Anticoagulant therapy in patients with atrial fibrillation: the experience of the Centers of Surveillance. Study group of the "Italian Study on Complications of Oral Anticoagulant Therapy" (ISCOAT) Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 11(Suppl 2): 18s-20s
Sarig, G.; Garach-Jehoshua, O.; Deutch, V.; Winder, A.; Hyam, E.; Katz, B.Zion.; Lahav, J.; Cassel, A.; Zivelin, A.; Souroujon, M.; Shimron, O. 2010: Laboratory evaluation of lupus anticoagulant in Israel Harefuah 149(5): 288-290; 336
Sasaki, M.; Hashimoto, E. 1991: Systematization of clinical laboratory--some problems caused from specimen transport through laboratory reports Rinsho Byori. Japanese Journal of Clinical Pathology 39(10): 1022-1027